BOK Financial’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.26M | Sell |
11,580
-3,411
| -23% | -$707K | 0.03% | 314 |
|
|
2026
Q1 | $3.37M | Sell |
14,991
-230
| -2% | -$57.3K | 0.05% | 250 |
|
|
2025
Q4 | $3.67M | Sell |
15,221
-1,761
| -10% | -$450K | 0.06% | 233 |
|
|
2025
Q3 | $4.65M | Sell |
16,982
-640
| -4% | -$175K | 0.07% | 217 |
|
|
2025
Q2 | $4.55M | Sell |
17,622
-2,788
| -14% | -$665K | 0.07% | 213 |
|
|
2025
Q1 | $4.57M | Sell |
20,410
-531
| -3% | -$124K | 0.08% | 207 |
|
|
2024
Q4 | $4.9M | Buy |
20,941
+441
| +2% | +$106K | 0.08% | 200 |
|
|
2024
Q3 | $4.89M | Buy |
20,500
+3,142
| +18% | +$702K | 0.09% | 199 |
|
|
2024
Q2 | $3.32M | Buy |
17,358
+15,323
| +753% | +$3.11M | 0.06% | 274 |
|
|
2024
Q1 | $385K | Sell |
2,035
-23
| -1% | -$4.21K | 0.01% | 599 |
|
|
2023
Q4 | $354K | Buy |
2,058
+617
| +43% | +$94.8K | 0.01% | 592 |
|
|
2023
Q3 | $203K | Sell |
1,441
-2,739
| -66% | -$495K | ﹤0.01% | 638 |
|
|
2023
Q2 | $913K | Sell |
4,180
-10
| -0.2% | -$2.23K | 0.02% | 472 |
|
|
2023
Q1 | $918K | Sell |
4,190
-9,668
| -70% | -$2.1M | 0.02% | 469 |
|
|
2022
Q4 | $2.88M | Sell |
13,858
-106
| -0.8% | -$23.3K | 0.05% | 308 |
|
|
2022
Q3 | $3.05M | Buy |
13,964
+141
| +1% | +$32.1K | 0.06% | 280 |
|
|
2022
Q2 | $2.9M | Sell |
13,823
-54
| -0.4% | -$11.5K | 0.06% | 295 |
|
|
2022
Q1 | $3.37M | Sell |
13,877
-62
| -0.4% | -$15K | 0.06% | 288 |
|
|
2021
Q4 | $3.63M | Buy |
13,939
+199
| +1% | +$51.6K | 0.06% | 292 |
|
|
2021
Q3 | $3.62M | Buy |
+13,740
| New | +$3.76M | 0.06% | 294 |
|
|
2021
Q1 | $2.18M | Buy |
11,256
+1,085
| +11% | +$218K | 0.04% | 372 |
|
|
2020
Q4 | $2.16M | Sell |
10,171
-1,117
| -10% | -$223K | 0.04% | 349 |
|
|
2020
Q3 | $1.94M | Sell |
11,288
-1,878
| -14% | -$347K | 0.04% | 330 |
|
|
2020
Q2 | $2.53M | Buy |
13,166
+1,515
| +13% | +$248K | 0.06% | 282 |
|
|
2020
Q1 | $1.72M | Buy |
11,651
+616
| +6% | +$98.1K | 0.05% | 312 |
|
|
2019
Q4 | $1.71M | Buy |
11,035
+215
| +2% | +$31K | 0.04% | 394 |
|
|
2019
Q3 | $1.46M | Buy |
10,820
+209
| +2% | +$27.4K | 0.04% | 415 |
|
|
2019
Q2 | $1.29M | Buy |
10,611
+22
| +0.2% | +$2.44K | 0.03% | 432 |
|
|
2019
Q1 | $1.1M | Buy |
10,589
+73
| +0.7% | +$7.54K | 0.03% | 461 |
|
|
2018
Q4 | $1.2M | Sell |
10,516
-167
| -2% | -$17.9K | 0.03% | 420 |
|
|
2018
Q3 | $1.23M | Buy |
10,683
+1,915
| +22% | +$210K | 0.03% | 465 |
|
|
2018
Q2 | $908K | Hold |
8,768
| – | – | 0.02% | 504 |
|
|
2018
Q1 | $863K | Buy |
8,768
+33
| +0.4% | +$3.12K | 0.02% | 505 |
|
|
2017
Q4 | $740K | Buy |
8,735
+10
| +0.1% | +$826 | 0.02% | 558 |
|
|
2017
Q3 | $671K | Sell |
8,725
-90
| -1% | -$6.88K | 0.02% | 584 |
|
|
2017
Q2 | $686K | Buy |
8,815
+10
| +0.1% | +$715 | 0.02% | 555 |
|
|
2017
Q1 | $634K | Hold |
8,805
| – | – | 0.02% | 592 |
|
|
2016
Q4 | $546K | Hold |
8,805
| – | – | 0.02% | 612 |
|
|
2016
Q3 | $570K | Hold |
8,805
| – | – | 0.02% | 597 |
|
|
2016
Q2 | $557K | Buy |
8,805
+10
| +0.1% | +$589 | 0.02% | 563 |
|
|
2016
Q1 | $509K | Buy |
8,795
+4,470
| +103% | +$253K | 0.02% | 569 |
|
|
2015
Q4 | $232K | Sell |
4,325
-3,300
| -43% | -$186K | 0.01% | 760 |
|
|
2015
Q3 | $389K | Sell |
7,625
-3,654
| -32% | -$197K | 0.01% | 616 |
|
|
2015
Q2 | $636K | Buy |
11,279
+8,019
| +246% | +$506K | 0.02% | 544 |
|
|
2015
Q1 | $234K | Buy |
+3,260
| New | +$212K | 0.01% | 741 |
|
|
2014
Q4 | – | Sell |
-3,127
| Closed | -$154K | – | 772 |
|
|
2014
Q3 | $154K | Sell |
3,127
-67
| -2% | -$3.41K | 0.01% | 819 |
|
|
2014
Q2 | $161K | Buy |
+3,194
| New | +$158K | 0.01% | 888 |
|
|
2013
Q4 | – | Sell |
-11,018
| Closed | -$582K | – | 889 |
|
|
2013
Q3 | $582K | Buy |
11,018
+452
| +4% | +$21.9K | 0.02% | 540 |
|
|
2013
Q2 | $477K | Buy |
+10,566
| New | +$501K | 0.02% | 540 |
|
Other funds holding RMD
BOK Financial's RMD Position: Q2 2026 in Review
BOK Financial reduced its ResMed (RMD) stake by 23% in Q2 2026, selling an estimated $707K and leaving 11,580 shares worth $2.26M. The position accounts for 0.03% of the portfolio, ranked #314.
BOK Financial first reported a position in RMD in Q2 2013 and has held it in 49 quarters since. The position peaked at $4.9M in Q4 2024. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- BOK Financial held 11,580 shares of ResMed worth $2.26M as of Q2 2026.
- BOK Financial sold 3,411 ResMed shares in Q2 2026, an estimated $707K.
- ResMed made up 0.03% of BOK Financial's portfolio in Q2 2026, its #314 holding.
- BOK Financial first reported a position in ResMed in Q2 2013 and has held it in 49 quarters since.
- BOK Financial's ResMed position peaked at $4.9M in Q4 2024.
- 880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on BOK Financial's 13F filing for Q2 2026, filed 10 Aug 2026.